“Beyond Reasonable Doubt - an Analysis of the Uncertainty Behind a Positive Test For

Total Page:16

File Type:pdf, Size:1020Kb

“Beyond Reasonable Doubt - an Analysis of the Uncertainty Behind a Positive Test For UNIVERSITY OF SOUTHAMPTON FACULTY OF MEDICINE HEALTH AND LIFE SCIENCES School of Medicine “Beyond Reasonable Doubt - An Analysis of the Uncertainty behind a Positive Test for Growth Hormone Abuse in Sport” by Ioulietta Erotokritou-Mulligan MSc, BSc(Hons) Thesis for the degree of Doctor of Philosophy June 2008 2 | P a g e ABSTRACT Growth hormone (GH) is a protein hormone which occurs naturally in the body and it is produced by the pituitary gland. The anabolic properties of GH have made this an attractive substance to be used by patients with catabolic medical problems and athletes that wish to enhance their athletic performance. However, to date, there is no scientific evidence to confirm that its use will enhance physical performance in sport. Aside from the morality issues regarding GH abuse in sports, the use of GH has been associated with a number of potential health risks. GH is on the International Olympic Committee (IOC) Prohibited Substance list. To date however, there is no established method available for detecting its abuse reliably. In 1999 the GH-2000 research group proposed a GH detection methodology to the IOC. The method uses the concentration values of two GH-dependent markers; Insulin Growth Factor-I (IGF-I) and Procollagen type III peptide (P-III-P). Concerns were raised by the IOC regarding the uncertainty involved in this methodology on areas such as the effect of ethnicity, injuries and the physiological variability on its ability to find an athlete guilty beyond reasonable doubt. The GH-2004 project was set up at the University of Southampton in order to address these issues by undertaking several studies to assess the effect of these potential confounding factors. This thesis used data collected by the GH-2004 project to examine the issues raised by the IOC. Furthermore, work was undertaken to validate the performance of the proposed method on independent data which will provide further evidence of the reliability of the GH-2000 detection method. An examination into the uncertainty surrounding the use of immunoassay methodology in this method was also carried out. This thesis demonstrates that the GH-2000 detection method is robust when used for individuals of any ethnic group regardless of any sport injuries experienced by athletes. Furthermore, it is shown that the physiological variability of the concentration of the two GH- dependent markers will not adversely affect the performance of this method. The validity of this method is also successfully demonstrated using independently collected data. Before this method is officially implemented, there is important laboratory analysis which needs to be undertaken, which will enable us to determine reliable cut-off limits, which will both maximise the sensitivity of the test but also reduce the rate of false positive results. It has been shown that this methodology is a powerful method and should help to cut down the abuse of GH. Keywords: Growth Hormone, Doping, Sports, IGF-I, Injury, Ethnicity, Physiological variability, Immunoassays 3 | P a g e ABBREVIATIONS ALS Acid-labile subunit BMI Body mass index CV Coefficient of variation EF3 Discriminant function for females EF3b Age-adjusted Discriminant function for females EM1 Discriminant function for males EM1b Age-adjusted discriminant function for males FDA Food and Drug Administration GH Growth hormone hGH Human growth hormone ICTP Carboxyl-terminal cross-linked telopeptide of type I collagen IGFBP IGF-binding protein IGF-I Insulin growth factor – I IOC International Olympic Committee OLR Ordinary Least-Squares Regression Osteo Osteocalcin PICP Carboxyl-terminal propeptide of type I procollagen 4 | P a g e P-III-P Procollagen type III peptide rhGH Recombinant human growth hormone Te Testosterone USADA United States Anti-Doping Agency WADA World Anti-Doping Agency 5 | P a g e DECLARATION OF AUTHORSHIP I, IOULIETTA EROTOKRITOU-MULLIGAN, declare that the thesis entitled “Beyond Reasonable Doubt - an Analysis of the Uncertainty behind a Positive Test for Growth Hormone Abuse” and the work presented in it are my own. I confirm that: this work was done wholly or mainly while in candidature for a research degree at this University; where any part of this thesis has previously been submitted for a degree or any other qualification at this University or any other institution, this has been clearly stated; where I have consulted the published work of others, this is always clearly attributed; where I have quoted from the work of others, the source is always given. With the exception of such quotations, this thesis is entirely my own work; I have acknowledged all main sources of help; where the thesis is based on work done by myself jointly with others, I have made clear exactly what was done by others and what I have contributed myself; none of this work has been published before submission Signed: ……………………………………………………………………….. Date:……………………………………………………………………………. 6 | P a g e ACKNOWLEDGEMENTS The principal investigators of the GH-2004 project were Dr. Richard I.G. Holt, Reader of Endocrinology and Metabolism at the University of Southampton and Professor Peter Sönksen, Emeritus Professor at the University of Southampton. Dr. Richard I.G. Holt was responsible for designing all studies covered in this project. Statistical input on the study design was made by Dr. Eryl Bassett, Senior Lecturer in Statistics at the University of Kent. The initial Ethics application for approval of these studies was made by Dr. Richard I.G. Holt. Subsequent revisions were made by the GH-2004 Research Fellow; Dr Cathy McHugh. Recruitment for study participants was undertaken by members of the GH-2004 project team; myself, Dr Richard I.G. Holt, Dr Cathy McHugh, Ms Clare Hartley (Project Manager 2002-2004), Mr Rod Park (Project Manager 2004-2006) and the medical students: Jenny Bacon, Kate Harrison, Ben Curtis, Luke Smith, Victoria Wells, Barnaby Fontaine and Polly Milward. Furthermore, Dr. Richard Seah recruited athletes with a sporting injury for the GH- 2004 Injury Study. Compliance assessments, sample collection and anthropological measurements were undertaken by Dr Cathy McHugh or under the supervision of Dr McHugh by one of the medical students involved in the GH-2004 project. Data quality assessment was a collective effort by the whole of the GH-2004 project team. Laboratory Analysis of samples collected by the GH-2004 project was undertaken by the WADA accredited laboratory at King’s College in London by Professor David Cowan and Mr Christiaan Bartlett. I would like to thank the nurses of the Wellcome Trust Clinical Research Facility at the University of Southampton for their assistance in recruitment and follow-up of the subjects. 7 | P a g e Furthermore, I would also like to thank Dr. Astrid Kniess and Professor Alessandro Sartorio for sharing the results of their studies for the purposes of the analysis presented in this thesis. In addition, I would like to acknowledge the support of Dr Richard Budgett, Director of Medical Services for the British Olympic Association. I would also like to acknowledge the legacy of the GH-2000 Project (a European Union ‘Biomed 2’ Project Contract umber: BMH4 CT950678). The GH-2004 study was funded by the World Anti-Doping Agency and US Anti-Doping Agency without which the studies described in this thesis would not have been possible. With the oversight of my supervisors, editorial advice has been sought. No changes of intellectual content were made as a result of this advice. 8 | P a g e SPECIAL ACKNOWLEDGEMENTS I would like to genuinely thank my supervisors (in no particular order) Dr Richard Holt, Dr Eryl Bassett and Professor Peter Sönksen for being a true inspiration and for looking after me so well the last few years. I feel incredibly blessed for having such an amazing supervisory team. I could not have done this without their support and help. I would also like to thank my parents, Erotokritos and Eve for believing in me and supporting me emotionally & financially all these years. Without their love, I would have probably given up a long time ago. Last, but definitely not least, the person I owe all of this to, is my beloved husband Stewart. I would like to thank him for looking after me better than an angel could, with infinite patience and love. I hope I can now finally return some favours. Thank you. 9 | P a g e To my angel, Stewart 10 | P a g e TABLE OF CONTENTS ABSTRACT ..................................................................................................................................................... 2 ACKNOWLEDGEMENTS ............................................................................................................................ 6 SPECIAL ACKNOWLEDGEMENTS ........................................................................................................... 8 LIST OF FIGURES ...................................................................................................................................... 18 CHAPTER 1: INTRODUCTION ........................................................................................................... 23 1.1 BACKGROUND TO THE RESEARCH .......................................................................................................... 24 1.2 JUSTIFICATION FOR THIS RESEARCH ..................................................................................................... 28 1.3 METHODOLOGY .......................................................................................................................................
Recommended publications
  • Impact of GH Administration on Athletic Performance in Healthy Young Adults: a Systematic Review and Meta-Analysis of Placebo-Controlled Trials MARK
    Growth Hormone & IGF Research 34 (2017) 38–44 Contents lists available at ScienceDirect Growth Hormone & IGF Research journal homepage: www.elsevier.com/locate/ghir Review Article Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials MARK ⁎ Kasper Hermansena, , Mads Bengtsena, Michael Kjærb, Peter Vestergaardc,d, Jens Otto Lunde Jørgensena a Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark b Institute of Sports Medicine, Department of Orthopedic Surgery M, Bispebjerg Hospital and Centre for Healthy Aging, Faculty of Health and Medical Science, University of Copenhagen, Denmark c Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark d Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark ARTICLE INFO ABSTRACT Keywords: Objective: Illicit use of growth hormone (GH) as a performance-enhancing drug among athletes is prevalent, GH although the evidence of such effects in healthy, young subjects is sparse. We therefore performed a meta- Athletic performance analysis of published studies on the effect of GH administration on body composition, substrate metabolism, and Doping athletic performance in healthy, young subjects. Design: The English-language based databases PubMed, EMBASE, and Cochrane Central Register of Controlled Trials were searched, and eligible articles were reviewed in accordance with the PRISMA guidelines. Fifty-four potentially relevant articles were retrieved of which 11 were included in this analysis comprising 254 subjects. Results: Administration of GH significantly increased lean body mass (p < 0.01) and decreased fat mass (p < 0.01). In addition, GH increased the exercising levels of glycerol (p = 0.01) and free fatty acids (p < 0.01), but did not alter the respiratory quotient during exercise (p = 0.30).
    [Show full text]
  • Hormone Abuse in Sports: the Antidoping Perspective
    Asian J Androl 2008; 10 (3): 391–402 DOI: 10.1111/j.1745-7262.2008.00402.x .Review . Hormone abuse in sports: the antidoping perspective Osquel Barroso, Irene Mazzoni, Olivier Rabin Science Department, World Anti-Doping Agency (WADA), Montreal, Quebec H4Z 1B7, Canada Abstract Since ancient times, unethical athletes have attempted to gain an unfair competitive advantage through the use of doping substances. A list of doping substances and methods banned in sports is published yearly by the World Anti- Doping Agency (WADA). A substance or method might be included in the List if it fulfills at least two of the following criteria: enhances sports performance; represents a risk to the athlete’s health; or violates the spirit of sports. This list, constantly updated to reflect new developments in the pharmaceutical industry as well as doping trends, enume- rates the drug types and methods prohibited in and out of competition. Among the substances included are steroidal and peptide hormones and their modulators, stimulants, glucocorticosteroids, β2-agonists, diuretics and masking agents, narcotics, and cannabinoids. Blood doping, tampering, infusions, and gene doping are examples of prohibited methods indicated on the List. From all these, hormones constitute by far the highest number of adverse analytical findings reported by antidoping laboratories. Although to date most are due to anabolic steroids, the advent of molecular biology techniques has made recombinant peptide hormones readily available. These substances are gradu- ally changing the landscape of doping trends. Peptide hormones like erythropoietin (EPO), human growth hormone (hGH), insulin, and insulin-like growth factor I (IGF-I) are presumed to be widely abused for performance enhancement.
    [Show full text]
  • Abstracts from the 9Th Biennial Scientific Meeting of The
    International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):15 DOI 10.1186/s13633-017-0054-x MEETING ABSTRACTS Open Access Abstracts from the 9th Biennial Scientific Meeting of the Asia Pacific Paediatric Endocrine Society (APPES) and the 50th Annual Meeting of the Japanese Society for Pediatric Endocrinology (JSPE) Tokyo, Japan. 17-20 November 2016 Published: 28 Dec 2017 PS1 Heritable forms of primary bone fragility in children typically lead to Fat fate and disease - from science to global policy a clinical diagnosis of either osteogenesis imperfecta (OI) or juvenile Peter Gluckman osteoporosis (JO). OI is usually caused by dominant mutations affect- Office of Chief Science Advsor to the Prime Minister ing one of the two genes that code for two collagen type I, but a re- International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):PS1 cessive form of OI is present in 5-10% of individuals with a clinical diagnosis of OI. Most of the involved genes code for proteins that Attempts to deal with the obesity epidemic based solely on adult be- play a role in the processing of collagen type I protein (BMP1, havioural change have been rather disappointing. Indeed the evidence CREB3L1, CRTAP, LEPRE1, P4HB, PPIB, FKBP10, PLOD2, SERPINF1, that biological, developmental and contextual factors are operating SERPINH1, SEC24D, SPARC, from the earliest stages in development and indeed across generations TMEM38B), or interfere with osteoblast function (SP7, WNT1). Specific is compelling. The marked individual differences in the sensitivity to the phenotypes are caused by mutations in SERPINF1 (recessive OI type obesogenic environment need to be understood at both the individual VI), P4HB (Cole-Carpenter syndrome) and SEC24D (‘Cole-Carpenter and population level.
    [Show full text]
  • Random Coefficient Repeated Measures Models
    (Entry for Encyclopaedia of Biostatistics, Armitage, P., & Colton,T. (Eds.), 1998, Wiley.) Random coefficient repeated measures models by Harvey Goldstein Institute of Education London, WC1H 0AL [email protected] Introduction This section is concerned with modelling data where measurements of one or more attributes are repeated on the same set of individuals over time. Typical applications are to the modelling of anthropometric growth of children or animals. The model specification will be developed for the case where a single continuous measurement is made on several occasions for a sample. This will then be extended to consider the case of multiple measurements at each time point and mention will be made of extensions to latent variable models and to discrete response data. To begin with we look at the simple, restricted, data structure where there are a fixed number of measurement occasions and each individual has a measurement at each occasion. Multivariate models Consider the data matrix of responses Individual Occasion 1 Occasion 2 Occasion 3 Occasion 4 1 y11 y21 y31 y41 2 y12 y22 y32 y42 3 y13 y23 y33 y43 The first subscript refers to occasion and the second to individual. We assume multivariate normality and so for the response vector we have initially YN~(,)µ Σ (1) This constitutes a null model and in general we will wish to include further variables, notably age or time. Suppose we wish to express the response, say a weight measurement, as a linear function of time (t) measured at each occasion. We may then write =+β β +ε ytij01 j j ij ij (2) where we allow the intercept and average growth rate to vary across individuals.
    [Show full text]
  • Environmental Pollution in Urban Environments and Human Biology
    7 Aug 2003 8:27 AR AR196-AN32-06.tex AR196-AN32-06.sgm LaTeX2e(2002/01/18) P1: IKH 10.1146/annurev.anthro.32.061002.093218 Annu. Rev. Anthropol. 2003. 32:111–34 doi: 10.1146/annurev.anthro.32.061002.093218 Copyright c 2003 by Annual Reviews. All rights reserved First published online as a Review in Advance on June 4, 2003 ENVIRONMENTAL POLLUTION IN URBAN ENVIRONMENTS AND HUMAN BIOLOGY Lawrence M. Schell and Melinda Denham Department of Anthropology, University at Albany, State University of New York, 1400 Washington Ave., Albany, New York, 12222; email: [email protected], [email protected] Key Words growth, lead, noise, stress, urbanism ■ Abstract The biocultural approach of anthropologists is well suited to understand the interrelationship of urbanism and human biology. Urbanism is a social construction that has continuously changed and presented novel adaptive challenges to its residents. Urban living today involves several biological challenges, of which one is pollution. Using three different types of pollutants as examples, air pollution, lead, and noise, the impact of pollution on human biology (mortality, morbidity, reproduction, and develop- ment) can be seen. Chronic exposure to low levels of these pollutants has a small impact on the individual, but so many people are exposed to pollution that the effect species- wide is substantial. Also, disproportionate pollutant exposure by socioeconomically disadvantaged groups exacerbates risk of poor health and well being. URBANISM AND HUMAN BIOLOGY Urban growth began slowly several thousand years ago and has accelerated tremen- dously over the past 300 years. By 2006, half of the world’s population will be living in urban places (United Nations 1998).
    [Show full text]
  • What Doctors and Scientists Are Saying About Human Growth Hormone in the Year 2003
    What Doctors and Scientists Are Saying About Human Growth Hormone in the Year 2003. TABLE OF CONTENTS H1 Disclaimer H2 Introduction H3 A String of Successes H3_1 A simple description of the growth hormone system. H3_2 Growth hormone treatment of growth hormone deficiency in children. H3_3 Growth hormone treatment of growth hormone deficiency in adults. H3_4 Growth hormone treatment of children and adults with kidney failure. H3_5 Growth hormone and Prader-Willi syndrome. H3_6 Growth hormone and cystic fibrosis. H3_7 Human growth hormone and Turner Syndrome. H3_8 Growth hormone and severe burns. H3_8_1 The metabolic consequences of severe burns. H3_8_2 The benefits of growth hormone therapy for burns H3_8_3 The disadvantages of growth hormone treatment for burns. H3_8_4 Drug combinations may bring burn therapy progress. H3_9 Growth hormone can reduce wasting in critically ill patients. H3_10 The effects of axis hormones on skin and wound healing. H3_11 Growth hormone therapy in HIV-infected patients. H3_12 Conclusions about hGH-responsive medical conditions. H4 A Promising Disappointment: Growth Hormone and Ageing. H4_1 Ageing, bone strength and growth hormone. H4_2 Age, muscle loss (sarcopenia) and growth hormone. H4_2_1 A description of age-related sarcopenia H4_2_2 The causes of age-related sarcopenia. H4_2_3 Exercise is the best antidote to sarcopenia. H4_2_4 Growth hormone may modestly increase muscular strength in the elderly. H4_2_5 Growth hormone increases lean mass, but the benefit is uncertain. H4_2_6 Innervation changes may enhance muscle strength. H4_2_7 Growth hormone resistance. H4_2_8 Exercise induces growth hormone. H4_2_9 Obesity decreases growth hormone secretion. H4_2_10 Locally produced IGF-I may dominate age-related sarcopenia H4_2_11 GH inducers can strengthen muscles in the elderly.
    [Show full text]
  • The Psychological Burden of Short Stature
    European Journal of Endocrinology (2004) 151 S29–S33 ISSN 0804-4643 The psychological burden of short stature: evidence against Linda D Voss and David E Sandberg1,2 Department of Endocrinology and Metabolism, Peninsula Medical School, Plymouth, UK, 1Departments of Psychiatry and Pediatrics, University of Buffalo, The State University of New York and 2the Women and Children’s Hospital of Buffalo, Buffalo, New York, USA (Correspondence should be addressed to L D Voss, EarlyBird Research Centre, Child Health, Level 12, Derriford Hospital, Plymouth PL6 8DH, UK; Email: [email protected]) Abstract Short stature, per se, is clearly not a disease, but is commonly perceived to be associated with social and psychological disadvantage. The assumption, widely held by pediatricians that short children are likely to be significantly affected by their stature, has been founded largely on older, poorly designed clinic-based studies and laboratory investigations of beliefs about the association between stature and individual characteristics. In contrast, data from more recent and better designed clinic- and commu- nity-based studies show that, in terms of psychosocial functioning, individuals with short stature are largely indistinguishable from their peers, whether in childhood, adolescence or adulthood. Parents and children alike should be reassured by these findings. In the absence of clear pathology, physical or psychological, GH therapy for the short but otherwise normal child raises ethical concerns about so-called ‘cosmetic endocrinology’. European Journal of Endocrinology 151 S29–S33 Introduction that SS constitutes a psychosocial burden (8). This belief is widespread. In a recent survey, 56% of phys- Short stature (SS) may result from an idiopathic icians felt that height impaired emotional well-being deficiency in growth hormone (GH) or be a feature of in children below the 3rd centile (9).
    [Show full text]
  • Absolute Or Relative Measures of Height and Weight&Quest
    European Journal of Clinical Nutrition (2015) 69, 647–648 © 2015 Macmillan Publishers Limited All rights reserved 0954-3007/15 www.nature.com/ejcn EDITORIAL Absolute or relative measures of height and weight? An Editorial European Journal of Clinical Nutrition (2015) 69, 647–648; interpret all individual growth data in the light of one international doi:10.1038/ejcn.2015.70 growth standard? Indian newborns are light and short5 when compared with WHO standards. We are used to explain anthropometric birth data In this volume, Spiegler and coworkers present their work on very from India by unfavourable maternal conditions. But also Indian low-birth weight infants (VLBW), they analysed at what age infants born to modern upper class women are shorter and lighter parents start complementary food in these infants, they deter- than WHO standards, and do not reflect maternal wealth and mined risk factors for early introduction of complementary food caste (Table 1). and they analysed whether the age at introduction of comple- Khadilkar and Khadilkar6 state: ‘The disadvantage of using mentary food influences height or weight at two years of age. The charts such as these (WHO charts) is that they are likely to over study is an important contribution to infant nutrition. But there is diagnose underweight and stunting in a large number of more to the study: the study was performed at the crossroads apparently normal children in the developing countries such as between nutrition and auxology. India’. Not only wealthy Indian children are shorter and lighter Studying nutrition and nutritional intervention on growth than these standards.
    [Show full text]
  • UCLA Electronic Theses and Dissertations
    UCLA UCLA Electronic Theses and Dissertations Title Growing Taller, yet Falling Short: Policy, Health, and Living Standards in Brazil, 1850-1950. Permalink https://escholarship.org/uc/item/7nn3b9g6 Author Franken, Daniel W. Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA Los Angeles Growing Taller, yet Falling Short: Policy, Health, and Living Standards in Brazil, 1850-1950 A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in History by Daniel William Franken 2016 ! © Copyright by Daniel William Franken 2016 ABSTRACT OF THE DISSERTATION Growing Taller, yet Falling Short: Policy, Health, and Living Standards in Brazil, 1850-1950 by Daniel William Franken Doctor of Philosophy in History University of California, Los Angeles, 2016 Professor William R. Summerhill, Chair The emergence of regional inequities and the genesis of modern economic growth in Brazil have remained shrouded by a dearth of historical evidence. Although quantitative scholars have revealed the efficacy of the First Republic (1889-1930) in fomenting economic progress, the extent to which Brazil’s early economic growth fostered improvements in health remains unclear. My dissertation fills this void in scholarship by relying on hitherto untapped archival sources with data on human stature—a reliable metric for health and nutritional status. Heights offer an excellent source of knowledge regarding human development for Brazil in the 1850-1950 period—an era of deep social, political, and economic transformations. My analysis centers heavily on a large (n≈17,000), geographically- comprehensive series compiled from military inscription files, supplemented by an ancillary dataset drawn from passport records (n≈6,000).
    [Show full text]
  • An Intellectual Odyssey
    "Malnutrition": An Intellectual Odyssey David Seckler When President Young asked me to "malnutrition". Under one criterion proper address this meeting of the Western Agricul- nutrition is defined as sufficient intake of tural Economics Association on my work in nutrients to reach the full genetic growth nutrition policy I gladly accepted for I have potential of the individual defined by various been spending most of my time talking to anthropometric and nutritional standards. nutritionists about these problems and Malnutrition then becomes abnormally low perhaps not enough time talking to my fellow size and/or consumption. Under the second agricultural economists. I say this not only criterion, malnutrition is defined in terms of because of the obvious connection between certain clinical signs of nutritional inadequa- nutrition, food policy and agriculture but cy and/or indices of functional impairment, because of a discovery, in my opinion, of such as the inability to work productively. considerable consequence. This discovery is Proper nutrition then presumably becomes that the concept of "malnutrition" cannot be the absence of these clinical-functional signs comprehended except in terms of the eco- of malnutrition. The problem is that most of nomic theory of optimality. the people who are not "properly nourished" In order to understand what I mean by this under the first criterion are also not "mal- statement it is first necessary to understand nourished" under the second criterion! "malnutrition" is an extremely ambiguous There exists a considerable "grey area", word. The Random House Dictionary, for consisting of perhaps as much as 80% or more example, defines "malnutrition" as "lack of of the conventionally estimated world of proper nutrition." Since "proper nutrition" is malnutrition, who are neither "properly not defined, one must simply assume that it nourished" nor "malnourished".
    [Show full text]
  • Barry M. Popkin, Phd W
    Barry M. Popkin, PhD W. R. Kenan Jr. Distinguished Professor Department of Nutrition Gillings School of Global Public Health The University of North Carolina at Chapel Hill Home address: 104 Mill Run Dr. Chapel Hill, NC 27514-3134 Office Address: Carolina Population Center Campus Box 8120 137 E. Franklin St. Chapel Hill, NC 27516-3997 Phone: (919) 962-6139 Fax: (919) 966-9159/919-445-0740 Email: [email protected] Website: www.nutrans.org EDUCATION Ph.D., Cornell University, Agricultural Economics (1973-1974) M.S., University of Wisconsin, Economics (1968-1969) Other graduate work, University of Pennsylvania (1967-1968) B.S., University of Wisconsin, Honors in Economics (1962-1965, 1966-1967) Other undergraduate work, University of New Delhi (1965-1966) FIELDS OF INTEREST Program and policy research to arrest and prevent excessive energy imbalance and diabetes; The nutrition transition: patterns and Determinants of Dietary Trends and body composition trends (United States and many low- and middle-income countries); Obesity dynamics and their environmental causes; Dietary and physical activity patterns, trends and determinants; The creation of large-scale program and policy initiatives to address nutrition-related noncommunicable diseases. CURRENT POSITION Distinguished Professor, Department of Nutrition Fellow, Carolina Population Center Director, The Nutrition Transition Research Program Rev. January 2017 Adjunct Professor, Department of Economics Member, UNC Lineberger Comprehensive Cancer Center Editorial Board, PLOS Medicine, Economics and Human Biology, Appetite, Risk Management and Healthcare Policy, The Lancet Diabetes & Endocrinology, Lifestyle Medicine - Research, Prevention & Treatment of Noncommunicable Diseases SELECTED HONORS AND AWARDS (2016) World Obesity Federation Population Science & Public Health Award (2015) Chinese government’s first award for significant foreign contributions to Chinese Nutrition (2015) Conrad A.
    [Show full text]
  • Proefschrift Door
    STRIKING THE RIGHT BALANCE Effectiveness of Anti-Doping Policies ZOEKEN NAAR HET JUISTE EVENWICHT Effectiviteit van het anti-dopingbeleid (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. G.J. van der Zwaan, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op vrijdag 18 november 2016 des middags te 2.30 uur door Olivier Matthijs de Hon geboren op 3 september 1972 te Amsterdam Promotor: Prof.dr. M. van Bottenburg Dit proefschrift werd mede mogelijk gemaakt met financiële steun van het Ministerie van Volksgezondheid, Welzijn en Sport. In mooie herinnering aan Julie, die altijd overal bij zal zijn In loving memory of Julie, who will always be present at all occasions Assessment Committee: Prof.dr. F.J.G. Backx (Utrecht University) Prof.dr. J.P.P.E.F. Boselie (Utrecht University) Prof.dr. J. Hoberman (University of Texas at Austin) Prof.dr. M.J. McNamee (Swansea University) Prof.dr. V. Møller (Aarhus University) On the day of thesis defence the Doctoral Examination Committee will also include: Prof.dr. M. van den Berg (Utrecht University) Prof.dr. M. Olfers (VU University Amsterdam) Prof.dr. S.H. Backhouse (Leeds Beckett University) The time to write this thesis was partially made available by means of a grant from the Dutch Ministry of Health, Welfare, and Sports. Printing this thesis has been financially enabled by Anti-Doping Authority Netherlands, also known as ‘Dopingautoriteit’. All views presented in this thesis are solely the individual views of the author and are by no means official policy statements of any organisation.
    [Show full text]